NATCO PHARMA LIMITED (INDIA)
Rasburicase-rasburnat
“Rasburicase” is the Drug / Molecule content in "Rasburnat". Rasburicase is a urate-oxidase enzyme. When chemotherapy is given, cancer cells are destroyed, releasing large amounts of uric acid into the blood. Rasburicase works by allowing uric acid to be more easily removed from the body by the kidneys.
Indication
It is used for preventing high blood levels of uric acid from occurring in patients with certain types of cancer (eg, leukemia, lymphoma, solid malignant tumors) who are receiving cancer chemotherapy treatment.
Note
Precaution
- Rasburicase is a prescription drug and should be used under proper medical guidance and advice.
- Rasburicase can cause severe hypersensitivity reactions including anaphylaxis.
Updated On Oct 31, 2019 by Admin
Strength
1.5 mg
Packing
Vial
Storage
Store between 2-8°C
Was this page helpful?
Related Products
CIPLA LTD.
Daunotec
Bristol & Myer’s Squibb
Sprycel
Roche
Vesanoid
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)